Trial
NCT04931667
3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Biosplice Therapeutics, Inc.
Collaborators
—
Condition
Osteoarthritis of the Knee
Intervention
Lorecivivint
Why stopped
Study was terminated by Sponsor based on a business decision not due to safety. The study report was finalized without any statistical analysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-31